A detailed history of Sowell Financial Services LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sowell Financial Services LLC holds 25,310 shares of NVO stock, worth $2.66 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
25,310
Previous 68,446 63.02%
Holding current value
$2.66 Million
Previous $9.77 Million 69.16%
% of portfolio
0.14%
Previous 0.48%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$119.07 - $145.42 $5.14 Million - $6.27 Million
-43,136 Reduced 63.02%
25,310 $3.01 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $651,835 - $780,385
5,312 Added 8.41%
68,446 $9.77 Million
Q1 2024

May 03, 2024

BUY
$102.11 - $135.92 $1.94 Million - $2.59 Million
19,026 Added 43.14%
63,134 $8.11 Million
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $1.91 Million - $2.3 Million
21,775 Added 97.5%
44,108 $4.56 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $2.03 Million - $4.46 Million
22,333 New
22,333 $2.03 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $363,008 - $436,521
2,743 New
2,743 $436,000
Q2 2021

Aug 05, 2021

SELL
$67.66 - $84.76 $257,987 - $323,189
-3,813 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$67.06 - $75.82 $7,175 - $8,112
-107 Reduced 2.73%
3,813 $283,000
Q4 2020

Jan 13, 2021

BUY
$63.89 - $73.8 $6,452 - $7,453
101 Added 2.64%
3,920 $274,000
Q3 2020

Nov 12, 2020

SELL
$63.69 - $70.22 $4,521 - $4,985
-71 Reduced 1.83%
3,819 $265,000
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $76,336 - $88,593
1,304 Added 50.43%
3,890 $255,000
Q1 2020

May 12, 2020

SELL
$49.46 - $64.78 $67,562 - $88,489
-1,366 Reduced 34.56%
2,586 $156,000
Q4 2019

Feb 07, 2020

SELL
$49.86 - $58.26 $2,692 - $3,146
-54 Reduced 1.35%
3,952 $228,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $190,445 - $214,040
4,006 New
4,006 $207,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.